Načítá se...
Targeted Activation of T Cells with IL-2-Coupled Nanoparticles
Interleukin-2 (IL-2) is a T cell growth factor particularly required in regulatory T cell maintenance and memory T cell responses. High-dose IL-2 treatment was the first FDA-approved immunotherapy for cancer, while low-dose IL-2 administration has shown promise in allograft rejection and autoimmune...
Uloženo v:
| Vydáno v: | Cells |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565705/ https://ncbi.nlm.nih.gov/pubmed/32917054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9092063 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|